A Direct-to-Patient Mindset and Model Emerges

Fact: Despite technological advances, patients are still waiting months to see a provider and their treatment journeys are fraught with delays, complexity and frustration. Additionally, the traditional commercialization model is fragmented, inefficient and restrictive, leading to significant delays in patients’ access to treatment and script lift.

Patients and brand teams expect – and deserve – better.

EVERSANA’s fully integrated Direct-to-Patient Model is proven to drive brand adoption, personalize care, and enhance the patients’ experience with pharma brands throughout their treatment journey – from diagnosis to affordability and long-term adherence.

As the industry’s first and only patient-led, fully integrated care model, EVERSANA is accelerating patients’ access to providers and treatments while offering the latest affordability automation and price transparency. By combining the forces of social media targeting, advertising, specialized field deployment, telehealth, pharmacy billing, benefit verification, reimbursement and dispensing, this commercial model is truly disrupting the care ecosystem.

By providing a patient-facing, technology-enabled model – as one channel within the overall commercialization strategy – brand teams can support patients in ways that are more empowering and results-oriented. DTP should now be viewed as a commercial model deployed strategically for operational efficiency and cost reduction while improving health outcomes.